{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:08:11Z","timestamp":1790892491795,"version":"4.1.0"},"reference-count":85,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Helmsley Trust"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Novel technology is one of the five focus areas of the Challenges in Inflammatory Bowel Disease (IBD) Research 2024 document. Building off the Challenges in IBD Research 2019 document, the Foundation aims to provide a comprehensive overview of current gaps in IBD research and deliver actionable approaches to address them with a focus on how these gaps can lead to advancements in interception, remission, and restoration for these diseases. The document is the result of a multidisciplinary collaboration from scientists, clinicians, patients, and funders and represents a valuable resource for patient-centric research prioritization.<\/jats:p>\n               <jats:p>Specifically, the Novel Technologies section focuses on addressing key research gaps to enable interception and improve remission rates in IBD. This includes testing predictions of disease onset and progression, developing novel technologies tailored to specific phenotypes, and facilitating collaborative translation of science into diagnostics, devices, and therapeutics.<\/jats:p>\n               <jats:p>Proposed priority actions outlined in the document include real-time measurement of biological changes preceding disease onset, more effective quantification of fibrosis, exploration of technologies for local treatment of fistulas, and the development of drug delivery platforms for precise, location-restricted therapies. Additionally, there is a strong emphasis on fostering collaboration between various stakeholders to accelerate progress in IBD research and treatment.<\/jats:p>\n               <jats:p>Addressing these research gaps necessitates the exploration and implementation of bio-engineered novel technologies spanning a spectrum from materials to systems. By harnessing innovative ideas and technologies, there\u2019s a collective effort to enhance patient care and outcomes for individuals affected by IBD.<\/jats:p>","DOI":"10.1093\/ibd\/izae082","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T08:38:50Z","timestamp":1716453530000},"page":"S30-S38","source":"Crossref","is-referenced-by-count":7,"title":["Challenges in IBD Research 2024: Novel Technologies"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2404-3801","authenticated-orcid":false,"given":"Shalini","family":"Prasad","sequence":"first","affiliation":[{"name":"Department of Bioengineering, The University of Texas at Dallas , Richardson, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond K","family":"Cross","sequence":"additional","affiliation":[{"name":"Director of the Inflammatory Bowel Disease Program, University of Maryland School of Medicine , Maryland, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Monroe","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Chemical Engineering BioInspired Syracuse: Institute for Material and Living Systems, Syracuse University , Syracuse, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-4948","authenticated-orcid":false,"given":"Michael T","family":"Dolinger","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, Division of Pediatric Gastroenterology , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Motte","sequence":"additional","affiliation":[{"name":"TISSIUM , 74 Rue du Faubourg Saint-Antoine, Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungmo","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, The University of Texas at Dallas , Richardson, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan W","family":"Stidham","sequence":"additional","affiliation":[{"name":"Department of Computational Medicine and Bioinformatics, University of Michigan , Ann Arbor, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Science, ILR-College of Pharmacy, Texas A&M University , TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, The University of Texas at Dallas , Richardson, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Larijani","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, The University of Texas at Dallas , Richardson, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Simone","sequence":"additional","affiliation":[{"name":"Department of Bioengineering, The University of Texas at Dallas , Richardson, TX ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A","family":"Chachu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Gastroenterology, Duke University School of Medicine , Durham, NC ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Wyborski","sequence":"additional","affiliation":[{"name":"Members of the Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caren A","family":"Heller","sequence":"additional","affiliation":[{"name":"Members of the Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan C","family":"Moss","sequence":"additional","affiliation":[{"name":"Members of the Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8248-4963","authenticated-orcid":false,"given":"Nicole M J","family":"Schwerbrock","sequence":"additional","affiliation":[{"name":"Members of the Crohn\u2019s & Colitis Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin M","family":"Selaru","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Oncology and Biomedical Engineering, Institute for Nanobiotechnology, Johns Hopkins University , Baltimore, MD ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"issue":"Suppl 2","key":"2025062417021450100_CIT0001","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1093\/ibd\/izz077","article-title":"Challenges in IBD research: novel technologies","volume":"25","author":"Dhyani","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"2025062417021450100_CIT0002","doi-asserted-by":"publisher","first-page":"110846","DOI":"10.1016\/j.ejrad.2023.110846","article-title":"PET\/MR enterography in inflammatory bowel disease: a review of applications and technical considerations","volume":"163","author":"Borhani","year":"2023","journal-title":"Eur J Radiol."},{"issue":"10","key":"2025062417021450100_CIT0003","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3390\/diagnostics11101926","article-title":"Diagnostic accuracy of noninvasive imaging for detection of colonic inflammation in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Alshammari","year":"2021","journal-title":"Diagnostics"},{"key":"2025062417021450100_CIT0004","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002632","article-title":"Determining the accuracy of intestinal ultrasound scores as a prescreening tool in Crohn\u2019s disease clinical trials","author":"Dolinger","year":"2023","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2025062417021450100_CIT0005","doi-asserted-by":"publisher","first-page":"741","DOI":"10.2174\/0929867328666201228124621","article-title":"Color doppler ultrasound assessment of clinical activity in inflammatory bowel disease","volume":"17","author":"Celikyay","year":"2021","journal-title":"Curr Med Imaging"},{"issue":"24","key":"2025062417021450100_CIT0006","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3390\/jcm12247569","article-title":"Leaving behind the mucosa: advances and future directions of intestinal ultrasound in ulcerative colitis","volume":"12","author":"Barchi","year":"2023","journal-title":"J Clin Med"},{"issue":"18","key":"2025062417021450100_CIT0007","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.3390\/jcm10184044","article-title":"Ultrasound elastography in the assessment of the intestinal changes in inflammatory bowel disease-systematic review","volume":"10","author":"\u015al\u00f3sarz","year":"2021","journal-title":"J Clin Med"},{"key":"2025062417021450100_CIT0008","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/CEG.S404009","article-title":"PSMA-targeted PET radiotracer [18F]DCFPyL as an imaging biomarker in inflammatory bowel disease","volume":"16","author":"Ismail","year":"2023","journal-title":"Clin Exp Gastroenterol"},{"issue":"8","key":"2025062417021450100_CIT0009","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2967\/jnumed.122.263922","article-title":"FAPI PET opens a new window to understanding immune-mediated inflammatory diseases","volume":"63","author":"Kuwert","year":"2022","journal-title":"J Nucl Med."},{"issue":"3","key":"2025062417021450100_CIT0010","doi-asserted-by":"publisher","first-page":"e222389","DOI":"10.1148\/radiol.222389","article-title":"Evaluation of intestinal fibrosis with 68Ga-FAPI PET\/MR enterography in Crohn disease","volume":"307","author":"Scharitzer","year":"2023","journal-title":"Radiology."},{"issue":"10","key":"2025062417021450100_CIT0011","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1093\/ibd\/izaa191","article-title":"A sweat-based wearable enabling technology for real-time monitoring of IL-1\u03b2 and CRP as potential markers for inflammatory bowel disease","volume":"26","author":"Jagannath","year":"2020","journal-title":"Inflamm Bowel Dis."},{"issue":"Supplement_1","key":"2025062417021450100_CIT0012","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1093\/ibd\/izac247.037","article-title":"Longitudinal monitoring of inflammatory bowel disease activity using wearable devices through inflammatory markers in sweat","volume":"29","author":"Hirten","year":"2023","journal-title":"Inflamm Bowel Dis."},{"key":"2025062417021450100_CIT0013","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.biosx.2023.100435","article-title":"Longitudinal monitoring of IL-6 and CRP in inflammatory bowel disease using IBD-AWARE","volume":"16","author":"Hirten","year":"2024","journal-title":"Biosens Bioelectron X"},{"issue":"1","key":"2025062417021450100_CIT0014","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1038\/s41598-024-53522-1","article-title":"Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable device","volume":"14","author":"Hirten","year":"2024","journal-title":"Sci Rep."},{"issue":"4","key":"2025062417021450100_CIT0015","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.giec.2022.05.011","article-title":"Overview of common complications in inflammatory bowel disease surgery","volume":"32","author":"Bakes","year":"2022","journal-title":"Gastrointest Endosc Clin N Am."},{"issue":"11","key":"2025062417021450100_CIT0016","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1093\/ibd\/izab361","article-title":"INSPECT: a retrospective study to evaluate long-term effectiveness and safety of darvadstrocel in patients with perianal fistulizing Crohn\u2019s disease treated in the ADMIRE-CD trial","volume":"28","author":"Pan\u00e9s","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025062417021450100_CIT0017","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcyt.2022.11.011","article-title":"Misconceptions, hurdles and recommendations regarding the use of mesenchymal stem\/stromal cells in perianal Crohn disease","volume":"25","author":"Ciccocioppo","year":"2023","journal-title":"Cytotherapy."},{"key":"2025062417021450100_CIT0018","author":"Tigenix S.A.U., ClinicalTrials.gov ID NCT03279081"},{"issue":"2","key":"2025062417021450100_CIT0019","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1097\/DCR.0000000000002767","article-title":"Direct injection of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of pediatric Crohn\u2019s perianal fistulizing disease","volume":"67","author":"Lightner","year":"2024","journal-title":"Dis Colon Rectum."},{"issue":"2","key":"2025062417021450100_CIT0020","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.surg.2023.07.020","article-title":"A phase IB\/IIA study of ex vivo expanded allogeneic bone marrow-derived mesenchymal stem cells for the treatment of rectovaginal fistulizing Crohn\u2019s disease","volume":"175","author":"Lightner","year":"2024","journal-title":"Surgery."},{"issue":"2","key":"2025062417021450100_CIT0021","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/DCR.0000000000002258","article-title":"Initial clinical outcomes using umbilical cord-derived tissue grafts to repair anovaginal fistula","volume":"66","author":"Godoy-Brewer","year":"2023","journal-title":"Dis Colon Rectum."},{"issue":"1","key":"2025062417021450100_CIT0022","doi-asserted-by":"publisher","first-page":"eade1067","DOI":"10.1126\/sciadv.ade1067","article-title":"A nanofiber-hydrogel composite improves tissue repair in a rat model of Crohn\u2019s disease perianal fistulas","volume":"9","author":"Li","year":"2023","journal-title":"Sci Adv."},{"issue":"1","key":"2025062417021450100_CIT0023","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1038\/s41467-023-39013-3","article-title":"Temperature-triggered in situ forming lipid mesophase gel for local treatment of ulcerative colitis","volume":"14","author":"Carone","year":"2023","journal-title":"Nat Commun."},{"issue":"4","key":"2025062417021450100_CIT0024","doi-asserted-by":"publisher","first-page":"otab045","DOI":"10.1093\/crocol\/otab045","article-title":"Development of a novel drug delivery system to deliver drugs directly to the colonic mucosa, resulting in improved efficacy and reduced systemic exposure for the treatment of ulcerative colitis","volume":"3","author":"Huntsman","year":"2021","journal-title":"Crohns Colitis 360"},{"issue":"16","key":"2025062417021450100_CIT0025","doi-asserted-by":"publisher","first-page":"e2000536","DOI":"10.1002\/adhm.202000536","article-title":"Heparin-coated albumin nanoparticles for drug combination in targeting inflamed intestine","volume":"9","author":"Zhang","year":"2020","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"2025062417021450100_CIT0026","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1038\/s41467-021-27463-6","article-title":"Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat Commun."},{"issue":"6","key":"2025062417021450100_CIT0027","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1053\/j.gastro.2023.01.006","article-title":"Injectable, drug-eluting nanocrystals prevent fibrosis and stricture formation in vivo","volume":"164","author":"Li","year":"2023","journal-title":"Gastroenterology."},{"issue":"8","key":"2025062417021450100_CIT0028","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/ibd\/izz289","article-title":"Potential of electrical neuromodulation for inflammatory bowel disease","volume":"26","author":"Cheng","year":"2020","journal-title":"Inflamm Bowel Dis."},{"issue":"4","key":"2025062417021450100_CIT0029","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1053\/j.gastro.2022.12.042","article-title":"Anti-integrin \u03b1v\u03b26 autoantibodies are a novel biomarker that antedate ulcerative colitis","volume":"164","author":"Livanos","year":"2023","journal-title":"Gastroenterology."},{"issue":"5","key":"2025062417021450100_CIT0030","doi-asserted-by":"publisher","first-page":"777","DOI":"10.14309\/ajg.0000000000000237","article-title":"Serum protein biomarkers of fibrosis aid in risk stratification of future stricturing complications in pediatric Crohn\u2019s disease","volume":"114","author":"Wu","year":"2019","journal-title":"Am J Gastroenterol."},{"issue":"6","key":"2025062417021450100_CIT0031","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased intestinal permeability is associated with later development of Crohn\u2019s disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology."},{"issue":"4","key":"2025062417021450100_CIT0032","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","article-title":"Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn\u2019s Disease","volume":"15","author":"Novak","year":"2021","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2025062417021450100_CIT0033","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cgh.2022.05.055","article-title":"Early ultrasound response and progressive transmural remission after treatment with ustekinumab in Crohn\u2019s disease","volume":"21","author":"Kucharzik","year":"2023","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2025062417021450100_CIT0034","doi-asserted-by":"publisher","first-page":"izad274","DOI":"10.1093\/ibd\/izad274","article-title":"Early intestinal ultrasound predicts clinical and endoscopic treatment response and demonstrates drug-specific kinetics in moderate-to-severe ulcerative colitis","author":"de Voogd","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"9","key":"2025062417021450100_CIT0035","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/gutjnl-2019-319451","article-title":"Intestinal ultrasound for monitoring therapeutic response in patients with ulcerative colitis: results from the TRUST&UC study","volume":"69","author":"Maaser","year":"2020","journal-title":"Gut."},{"issue":"4","key":"2025062417021450100_CIT0036","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cgh.2016.10.040","article-title":"Use of intestinal ultrasound to monitor Crohn\u2019s disease activity","volume":"15","author":"Kucharzik","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2025062417021450100_CIT0037","doi-asserted-by":"publisher","first-page":"jjad216","DOI":"10.1093\/ecco-jcc\/jjad216","article-title":"Early intestinal ultrasound response to biologic therapy predicts endoscopic remission in children with ileal Crohn\u2019s disease: results from the prospective super sonic study","author":"Dolinger","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2025062417021450100_CIT0038","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1053\/j.gastro.2022.07.048","article-title":"Development, validation, and evaluation of the pediatric inflammatory Crohn\u2019s magnetic resonance enterography index from the ImageKids Study","volume":"163","author":"Focht","year":"2022","journal-title":"Gastroenterology."},{"issue":"5","key":"2025062417021450100_CIT0039","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/ibd\/izab147","article-title":"Development and validation of a Pediatric MRI-Based Perianal Crohn Disease (PEMPAC) index-A report from the ImageKids Study","volume":"28","author":"Choshen","year":"2022","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025062417021450100_CIT0040","first-page":"182","article-title":"Comparative investigation of the results of EEG and C.A.T. in posttraumatic epilepsy (author\u2019s transl)","volume":"9","author":"Wessely","year":"1978","journal-title":"EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb"},{"issue":"2","key":"2025062417021450100_CIT0041","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/apt.15870","article-title":"Serum oncostatin M at baseline predicts mucosal healing in Crohn\u2019s disease patients treated with infliximab","volume":"52","author":"Bertani","year":"2020","journal-title":"Aliment Pharmacol Ther."},{"issue":"10","key":"2025062417021450100_CIT0042","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/apt.17731","article-title":"Systematic review: scores used to predict outcomes in acute severe ulcerative colitis","volume":"58","author":"Kayal","year":"2023","journal-title":"Aliment Pharmacol Ther."},{"key":"2025062417021450100_CIT0043","doi-asserted-by":"publisher","first-page":"gutjnl","DOI":"10.1136\/gutjnl-2023-329963","article-title":"Fibrosis in IBD: from pathogenesis to therapeutic targets","author":"Rieder","year":"2024","journal-title":"Gut."},{"issue":"19","key":"2025062417021450100_CIT0044","doi-asserted-by":"publisher","first-page":"6379","DOI":"10.3390\/jcm12196379","article-title":"Where are we and where to next?\u2014The future of perianal Crohn\u2019s disease management","volume":"12","author":"Anandabaskaran","year":"2023","journal-title":"JCM"},{"issue":"4","key":"2025062417021450100_CIT0045","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.giec.2022.04.006","article-title":"Endoscopic balloon dilation of strictures","volume":"32","author":"Sivasailam","year":"2022","journal-title":"Gastrointest Endosc Clin N Am."},{"issue":"8","key":"2025062417021450100_CIT0046","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.vgie.2018.11.002","article-title":"Endoscopic needle-knife stricturotomy for refractory choledochojejunal anastomotic stricture","volume":"4","author":"Yang","year":"2019","journal-title":"VideoGIE"},{"issue":"4","key":"2025062417021450100_CIT0047","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/MIB.0000000000001044","article-title":"Endoscopic stricturotomy with needle knife in the treatment of strictures from inflammatory bowel disease","volume":"23","author":"Lan","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2025062417021450100_CIT0048","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/ibd\/izab038","article-title":"The pathogenesis and clinical management of stricturing Crohn disease","volume":"27","author":"Schmoyer","year":"2021","journal-title":"Inflamm Bowel Dis."},{"issue":"17","key":"2025062417021450100_CIT0049","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3748\/wjg.v17.i17.2161","article-title":"Wound healing of intestinal epithelial cells","volume":"17","author":"Iizuka","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"9","key":"2025062417021450100_CIT0050","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","article-title":"A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn\u2019s disease","volume":"63","author":"Gecse","year":"2014","journal-title":"Gut."},{"issue":"1","key":"2025062417021450100_CIT0051","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ibd.20608","article-title":"Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn\u02bcs disease: a randomized, double-blind, placebo-controlled pilot study","volume":"15","author":"Thia","year":"2009","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025062417021450100_CIT0052","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","article-title":"Metronidazole therapy for perineal Crohn\u2019s disease: a follow-up study","volume":"83","author":"Brandt","year":"1982","journal-title":"Gastroenterology."},{"issue":"2","key":"2025062417021450100_CIT0053","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0016-5085(80)90155-9","article-title":"Healing of perineal Crohn\u2019s disease with metronidazole","volume":"79","author":"Bernstein","year":"1980","journal-title":"Gastroenterology."},{"issue":"19","key":"2025062417021450100_CIT0054","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMp1408040","article-title":"Antibiotic resistance \u2014 problems, progress, and prospects","volume":"371","author":"Nathan","year":"2014","journal-title":"N Engl J Med."},{"issue":"1","key":"2025062417021450100_CIT0055","doi-asserted-by":"publisher","first-page":"1725220","DOI":"10.1080\/19490976.2020.1725220","article-title":"Microbiota insight in Clostridium difficile infection and inflammatory bowel disease","volume":"12","author":"Rodr\u00edguez","year":"2020","journal-title":"Gut Microbes"},{"issue":"2","key":"2025062417021450100_CIT0056","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint","year":"2014","journal-title":"Gut."},{"issue":"8","key":"2025062417021450100_CIT0057","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","article-title":"Long-term outcome of perianal fistulizing Crohn\u2019s disease treated with infliximab","volume":"11","author":"Bouguen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"2025062417021450100_CIT0058","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1002\/art.10679","article-title":"Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration","volume":"46","author":"Brown","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2025062417021450100_CIT0059","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/s0016-5085(99)70294-5","article-title":"The relationship between infliximab treatment and lymphoma in Crohn\u2019s disease","volume":"117","author":"Bickston","year":"1999","journal-title":"Gastroenterology."},{"issue":"6","key":"2025062417021450100_CIT0060","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1155\/2001\/403102","article-title":"Anti-TNF therapy and malignancy \u2013 a critical review","volume":"15","author":"Cohen","year":"2001","journal-title":"Can J Gastroenterol."},{"issue":"5","key":"2025062417021450100_CIT0061","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10350-004-6611-4","article-title":"Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn\u2019s disease: a single center experience","volume":"46","author":"Topstad","year":"2003","journal-title":"Dis Colon Rectum"},{"issue":"10","key":"2025062417021450100_CIT0062","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cgh.2016.04.031","article-title":"Cumulative length of bowel resection in a population-based cohort of patients with Crohn\u2019s disease","volume":"14","author":"Peyrin-Biroulet","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"2025062417021450100_CIT0063","doi-asserted-by":"publisher","first-page":"S299","DOI":"10.1016\/S0002-9270(01)03728-5","article-title":"The epidemiology and natural history of Crohn\u2019s disease in population-based patient cohorts from North America: a systematic review","volume":"96","author":"Loftus","year":"2001","journal-title":"Am J Gastroenterol."},{"issue":"9","key":"2025062417021450100_CIT0064","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1177\/0003134820956331","article-title":"Modern management of perianal Crohn\u2019s disease: a review","volume":"87","author":"Williams","year":"2021","journal-title":"Am Surg."},{"issue":"11","key":"2025062417021450100_CIT0065","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1097\/MIB.0000000000001254","article-title":"Comparison of stromal vascular fraction with or without a novel bioscaffold to fibrin glue in a porcine model of mechanically induced anorectal fistula","volume":"23","author":"Dryden","year":"2017","journal-title":"Inflamm Bowel Dis."},{"issue":"1","key":"2025062417021450100_CIT0066","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13287-020-02095-7","article-title":"Efficacy of stem cells therapy for Crohn\u2019s fistula: a meta-analysis and systematic review","volume":"12","author":"Cao","year":"2021","journal-title":"Stem Cell Res Ther."},{"issue":"3","key":"2025062417021450100_CIT0067","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/stem.302","article-title":"Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex","volume":"28","author":"Song","year":"2010","journal-title":"Stem Cells."},{"issue":"44","key":"2025062417021450100_CIT0068","doi-asserted-by":"publisher","first-page":"eabb4133","DOI":"10.1126\/sciadv.abb4133","article-title":"Gastrointestinal-resident, shape-changing microdevices extend drug release in vivo","volume":"6","author":"Ghosh","year":"2020","journal-title":"Sci Adv."},{"issue":"11","key":"2025062417021450100_CIT0069","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41578-022-00477-2","article-title":"Mucosa-interfacing electronics","volume":"7","author":"Nan","year":"2022","journal-title":"Nat Rev Mater."},{"issue":"12","key":"2025062417021450100_CIT0070","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.tips.2020.09.014","article-title":"Electroceuticals in the gastrointestinal tract","volume":"41","author":"Ramadi","year":"2020","journal-title":"Trends Pharmacol Sci."},{"issue":"8","key":"2025062417021450100_CIT0071","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.2174\/0929867328666210617103905","article-title":"Ultrasound-based drug delivery system","volume":"29","author":"Ren","year":"2022","journal-title":"Curr Med Chem."},{"issue":"7","key":"2025062417021450100_CIT0072","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/jbm.a.37376","article-title":"Shape memory polymer hydrogels with cell-responsive degradation mechanisms for Crohn\u2019s fistula closure","volume":"110","author":"Beaman","year":"2022","journal-title":"J Biomedical Materials Res."},{"issue":"4","key":"2025062417021450100_CIT0073","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/jfb14040234","article-title":"Antimicrobial PVA hydrogels with tunable mechanical properties and antimicrobial release profiles","volume":"14","author":"Greene","year":"2023","journal-title":"J Funct Biomater"},{"key":"2025062417021450100_CIT0074","doi-asserted-by":"publisher","first-page":"1103709","DOI":"10.3389\/fbioe.2023.1103709","article-title":"Mesenchymal stem cell secretome-loaded fibrin glue improves the healing of intestinal anastomosis","volume":"11","author":"Yu","year":"2023","journal-title":"Front Bioeng Biotechnol."},{"issue":"19","key":"2025062417021450100_CIT0075","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1111\/jcmm.17483","article-title":"Effect of Crohn\u2019s disease mesenteric mesenchymal stem cells and their extracellular vesicles on T-cell immunosuppressive capacity","volume":"26","author":"Dadgar","year":"2022","journal-title":"J Cellular Molecular Medi"},{"key":"2025062417021450100_CIT0076","doi-asserted-by":"publisher","first-page":"122962","DOI":"10.1016\/j.ijpharm.2023.122962","article-title":"Bio-adhesive and ROS-scavenging hydrogel microspheres for targeted ulcerative colitis therapy","volume":"639","author":"Sun","year":"2023","journal-title":"Int J Pharm."},{"issue":"18","key":"2025062417021450100_CIT0077","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1039\/d1tb00499a","article-title":"Thermosensitive polymer hydrogel as a physical shield on colonic mucosa for colitis treatment","volume":"9","author":"Guo","year":"2021","journal-title":"J Mater Chem B."},{"issue":"9","key":"2025062417021450100_CIT0078","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1021\/acs.biomac.0c00589","article-title":"Curcumin nanocrystal\/pH-responsive polyelectrolyte multilayer core\u2013shell nanoparticles for inflammation-targeted alleviation of ulcerative colitis","volume":"21","author":"Oshi","year":"2020","journal-title":"Biomacromolecules"},{"key":"2025062417021450100_CIT0079","doi-asserted-by":"publisher","first-page":"111756","DOI":"10.1016\/j.colsurfb.2021.111756","article-title":"Commensal flora triggered target anti-inflammation of alginate-curcumin micelle for ulcerative colitis treatment","volume":"203","author":"Wang","year":"2021","journal-title":"Colloids Surf B."},{"issue":"47","key":"2025062417021450100_CIT0080","doi-asserted-by":"publisher","first-page":"55966","DOI":"10.1021\/acsami.1c19457","article-title":"Antioxidant enzymes sequestered within lipid\u2013polymer hybrid nanoparticles for the local treatment of inflammatory bowel disease","volume":"13","author":"Le","year":"2021","journal-title":"ACS Appl Mater Interfaces."},{"issue":"3","key":"2025062417021450100_CIT0081","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1021\/acsabm.3c00094","article-title":"Delivery of transcriptional factors for activating antioxidant defenses against inflammatory bowel disease","volume":"6","author":"Zeng","year":"2023","journal-title":"ACS Appl Bio Mater"},{"key":"2025062417021450100_CIT0082","doi-asserted-by":"publisher","first-page":"119413","DOI":"10.1016\/j.carbpol.2022.119413","article-title":"Starch hydrogels as targeted colonic drug delivery vehicles","volume":"289","author":"Koev","year":"2022","journal-title":"Carbohydr Polym."},{"key":"2025062417021450100_CIT0083","doi-asserted-by":"publisher","first-page":"121364","DOI":"10.1016\/j.biomaterials.2022.121364","article-title":"Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease","volume":"281","author":"Kotla","year":"2022","journal-title":"Biomaterials."},{"key":"2025062417021450100_CIT0084","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.4350141","article-title":"Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis by bilirubin encapsulated in hyaluronic acid-functionalized PLGA nanoparticles","author":"Zhuo","year":"2023","journal-title":"SSRN."},{"issue":"11","key":"2025062417021450100_CIT0085","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1128\/jb.169.11.5216-5223.1987","article-title":"Nucleotide sequence analysis of the gene encoding the Deinococcus radiodurans surface protein, derived amino acid sequence, and complementary protein chemical studies","volume":"169","author":"Peters","year":"1987","journal-title":"J Bacteriol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/Supplement_2\/S30\/58359560\/izae082.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/30\/Supplement_2\/S30\/58359560\/izae082.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T21:02:18Z","timestamp":1750798938000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/30\/Supplement_2\/S30\/7676451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":85,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2024,5,23]]},"published-print":{"date-parts":[[2024,5,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae082","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5,1]]},"published":{"date-parts":[[2024,5,1]]}}}